Brief: FDA Issues Reminder of Non-Substitution of PEDMARK for Pediatric Patients Receiving Cisplatin

Fennec Pharmaceuticals

01/02/2024 11:28

Feb 1 (Reuters) - Fennec Pharmaceuticals Inc  FENC.O :
    * FDA ISSUES REMINDER OF NON-SUBSTITUTION OF PEDMARK®
(SODIUM
THIOSULFATE INJECTION) FOR PEDIATRIC PATIENTS RECEIVING
CISPLATIN

Source text for Eikon:  ID:nGNXbZPCjM 
Further company coverage:  FENC.O 

 ((Reuters.Briefs@thomsonreuters.com;))